Skip to main content
    I

    Inhibrx Biosciences, Inc. (INBX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $77.66
    -5.64 (-6.77%)

    Market Cap: $1.23B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Inhibrx Biosciences, Inc. (INBX) Earnings: Report Dates and Results

    Updated Nov 13, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Inhibrx Biosciences (INBX) is expected to report earnings on Mar 17, 2027. In the quarter ended Sep 30, 2026, Inhibrx Biosciences reported EPS of -$2.46, above the -$2.50 estimate. It beat the EPS estimate in 4 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    50%(5/10)
    Avg Surprise
    -22.39%
    Streak
    2 Q

    Upcoming Estimates

    Reports Mar 17, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$2.84
    Range-$3.46 - -$2.42
    5 analysts
    Revenue Consensus
    N/A
    RangeN/A
    5 analysts

    Next Report

    INBX has an expected report date of Mar 17, 2027.

    Earnings History

    Of the 10 quarters below that had an estimate, INBX beat 5 and missed 5. The widest gap in the table came in the quarter ended Dec 31, 2024, when EPS landed 114.58% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$2.46-$2.50-$2.57 - -$2.14+1.60%BeatN/A20 up, 1 downNov 13, 2026$2.00M
    Jun 30, 2026-$2.34-$2.50N/A+6.40%BeatN/A10 up, 0 downAug 13, 2026N/A
    Mar 31, 2026-$2.15-$1.20-$1.20 - -$1.20-79.17%MissN/A11 up, 0 downMay 14, 2026N/A
    Dec 31, 2025-$2.11-$1.63N/A-29.45%MissN/A10 up, 1 downMar 19, 2026N/A
    Sep 30, 2025-$2.28-$1.72-$1.72 - -$1.72-32.56%MissN/A11 up, 0 downNov 14, 2025N/A
    Jun 30, 2025-$1.85-$2.60-$2.60 - -$2.60+28.85%Beat-101.5%11 up, 0 downAug 13, 2025$1.30M
    Mar 31, 2025-$2.80-$3.12N/A+10.26%BeatN/AN/AN/AMay 14, 2025N/A
    Dec 31, 2024-$3.09-$1.44N/A-114.58%MissN/AN/AN/AMar 17, 2025$100000
    Sep 30, 2024-$2.84-$3.70N/A+23.24%BeatN/AN/AN/ANov 14, 2024N/A
    Jun 30, 2024$125.48-$1.52N/AN/AN/AN/AN/AN/AAug 13, 2024$100000
    Mar 31, 2024-$1.44-$1.04N/A-38.46%MissN/AN/AN/AJun 3, 2024N/A
    Last 11 quarters

    Annual EPS

    Fiscal year endedEPSChange
    Sep 30, 2026-$6.95N/A
    Jun 30, 2026-$4.49N/A
    Dec 31, 2025-$9.04N/A
    Jun 30, 2025-$4.65-103.9%
    Dec 31, 2024$118.11N/A

    Frequently Asked Questions About INBX

    When is Inhibrx Biosciences's next earnings date?

    Inhibrx Biosciences's next earnings report is expected for Mar 17, 2027.

    Did INBX beat earnings estimates last quarter?

    Yes. Inhibrx Biosciences reported EPS of -$2.46 for the quarter ended Sep 30, 2026, above the -$2.50 estimate, a 1.60% surprise.

    What EPS do analysts expect from INBX next quarter?

    The consensus EPS estimate for Inhibrx Biosciences for the quarter ending Dec 31, 2026 is -$2.84 from 5 analysts, with estimates from -$3.46 to -$2.42.

    How often does INBX beat earnings estimates?

    Inhibrx Biosciences beat the EPS estimate in 4 of the last 8 quarters, with an average surprise of -26.08%.